Latest News

04.19.18

Allergan Will Not Bid for Shire: Sources

Source: Eyewire News

04.19.18

Novartis Confirms 2018 Targets as Alcon Recovery Gains Steam

Source: Reuters

04.19.18

Allergan Moves in as Shire Rebuffs $63 billion Takeda Bid

Source: Reuters

04.19.18

Nation’s Ophthalmologists Remind Congress of the Importance of Medical and Surgical Eye Care

Source: American Academy of Ophthalmology

04.19.18

Nine Members of Congress Honored for Efforts to Preserve Access to Quality Medical Eye Care

Source: American Academy of Ophthalmology

04.18.18

Telemedicine Useful in Detecting Retinopathy of Prematurity

Source: Reuters Health

04.18.18

Data from BioTime’s OpRegen and Retinal Restoration Programs to Be Presented at ARVO 2018

Source: BioTime

04.17.18

GlobalData: AI-Based Diabetic Retinopathy Device Can Reduce Burden on US Healthcare System

Source: GlobalData

04.16.18

Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

Source: Shire

04.15.18

Dark Adaptation Testing with AdaptDx Selected for Functional Assessment in Large EU Study

Source: MacuLogix

View more stories